期刊
HELIYON
卷 9, 期 9, 页码 -出版社
CELL PRESS
DOI: 10.1016/j.heliyon.2023.e20201
关键词
Engineered elastin-like polypeptide; Wound healing; Type II diabetes mellitus; Adipose -derived stem cells; Skin elasticity
This study proposes a method using extracellular matrix mimetic biomaterials for enhancing wound healing in diabetic patients. By using biosynthesized REPs, the efficacy of stem cells can be improved, leading to accelerated wound closure and improved skin elasticity, which is of great importance for the treatment of diabetes patients.
Impaired cutaneous wound healing is a major complication in patients with diabetes mellitus (DM), leading to increased amputation and mortality rates in affected patients. Adipose-derived stem cells (ASCs) are widely used seed cells for promoted tissue regeneration to improve wound closure under diabetic conditions. However, ASCs-based therapies remain limited due to diffi-culties in maintaining cell quality during transplantation. To overcome this problem, extracellular matrix mimetic biomaterials have been developed for use in biomedical engineering field, including tissue engineering and regenerative medicine. Herein, a biosynthesized arginine-gly-cine-aspartate amino acid residues (RGD motif, known as a cell adhesion motif)-containing elastin-like polypeptides (REPs) improved the efficacy of ASCs in enhancing wound closure and skin elasticity in diabetic wounds by promoting the expression of angiogenic growth factors. Therefore, REPs can be used as potential supplements to stem cell-based therapeutic approach to accelerate diabetic wound repair.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据